Potent Delivery of Functional Proteins into Mammalian Cells in Vitro and in Vivo Using a Supercharged Protein

The inability of proteins to potently penetrate mammalian cells limits their usefulness as tools and therapeutics. When fused to superpositively charged GFP, proteins rapidly (within minutes) entered five different types of mammalian cells with potency up to ∼100-fold greater than that of corresponding fusions with known protein transduction domains (PTDs) including Tat, oligoarginine, and penetratin. Ubiquitin-fused supercharged GFP when incubated with human cells was partially deubiquitinated, suggesting that proteins delivered with supercharged GFP can access the cytosol. Likewise, supercharged GFP delivered functional, nonendosomal recombinase enzyme with greater efficiencies than PTDs in vitro and also delivered functional recombinase enzyme to the retinae of mice when injected in vivo.

[1]  David R. Liu,et al.  Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins , 2009, Proceedings of the National Academy of Sciences.

[2]  E. Hall,et al.  The nature of biotechnology. , 1988, Journal of biomedical engineering.

[3]  T. Kitamura,et al.  Plat-E: an efficient and stable system for transient packaging of retroviruses , 2000, Gene Therapy.

[4]  J. Kreuter,et al.  Functional Protein Delivery into Neurons Using Polymeric Nanoparticles* , 2009, Journal of Biological Chemistry.

[5]  C. Glover,et al.  Gene expression profiling for hematopoietic cell culture , 2006 .

[6]  C. Gabel,et al.  Mannose 6-phosphate receptor-mediated endocytosis of acid hydrolases: internalization of beta-glucuronidase is accompanied by a limited dephosphorylation , 1986, The Journal of cell biology.

[7]  R. Awatramani,et al.  Assembly of the Brainstem Cochlear Nuclear Complex Is Revealed by Intersectional and Subtractive Genetic Fate Maps , 2006, Neuron.

[8]  S. Dowdy,et al.  Modulation of cellular function by TAT mediated transduction of full length proteins. , 2003, Current protein & peptide science.

[9]  David R. Liu,et al.  Supercharging proteins can impart unusual resilience. , 2007, Journal of the American Chemical Society.

[10]  John Calvin Reed,et al.  Intracellular Delivery of Proteins with a New Lipid-mediated Delivery System* , 2001, The Journal of Biological Chemistry.

[11]  H. Ploegh,et al.  A novel active site‐directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14 , 2001, The EMBO journal.

[12]  H. McLeod,et al.  The kinetics and tissue distribution of protein transduction in mice. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[13]  M. Brown,et al.  Visualization of acidic organelles in intact cells by electron microscopy. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Michel,et al.  A ubiquitin-based assay for the cytosolic uptake of protein transduction domains. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  P. Seglen,et al.  Inhibition of the lysosomal pathway of protein degradation in isolated rat hepatocytes by ammonia, methylamine, chloroquine and leupeptin. , 1979, European journal of biochemistry.

[16]  F. Guo,et al.  Structure of Cre recombinase complexed with DNA in a site-specific recombination synapse , 1997, Nature.

[17]  M. M. Pater,et al.  Transformation by purified early genes of simian virus 40. , 1984, Virology.

[18]  C. Cepko,et al.  Controlled expression of transgenes introduced by in vivo electroporation , 2007, Proceedings of the National Academy of Sciences.

[19]  M. Plotkin.  Nature as medicine. , 2005, Explore.

[20]  A. Hershko,et al.  Ubiquitin-aldehyde: a general inhibitor of ubiquitin-recycling processes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[21]  N. Bresolin,et al.  Intracellular delivery of a Tat-eGFP fusion protein into muscle cells. , 2001, Molecular Therapy.

[22]  A. Varshavsky.  Ubiquitin fusion technique and related methods. , 2005, Methods in enzymology.

[23]  Leonard I Zon,et al.  Cell stem cell. , 2007, Cell stem cell.

[24]  E. Kandel,et al.  Proceedings of the National Academy of Sciences of the United States of America. Annual subject and author indexes. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Kossiakoff,et al.  An engineered substance P variant for receptor-mediated delivery of synthetic antibodies into tumor cells , 2009, Proceedings of the National Academy of Sciences.

[26]  L. Juliano,et al.  Cathepsin B Activity Regulation , 2001, The Journal of Biological Chemistry.

[27]  R. Tsien,et al.  Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein , 2004, Nature Biotechnology.

[28]  M. Morris,et al.  Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics , 2009, British journal of pharmacology.